Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2005
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1282429A4 Pharmaceutical gel composition
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP1200053B1 Stable hydrogenated lupulone antibacterial oral compositions
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP0822988B1 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1711103A Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
12/21/2005CN1232535C GST fusion expression of conotoxin MVII A gene and its use
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232295C White flagger oral liquid and its preparing method
12/21/2005CN1232288C Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process
12/21/2005CN1232284C Chinese traditional medicine for treating infantile anorexia
12/21/2005CN1232272C Haigou-shenlong pill
12/21/2005CN1232271C Chinese medicine for curing gastropathy and enteropathy and preparation method thereof
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CN1232249C Application of chalcone for preparing medicines for treating hepatitis
12/21/2005CA2510887A1 A method for treating inflammatory bowel disease by oral administration of il-10
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/18/2005CA2504471A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117926A1 Agent for intestinal bacterial flora amelioration
12/15/2005WO2005117890A2 Thienopyrimidines and thiazolopyrimidines for use in medicine
12/15/2005WO2002094376A3 Compositions and methods for promoting or inhibiting ndpk
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277618 Methods
12/15/2005US20050277616 Thymine nucleosides with anti-hepatitis B virus activity
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277606 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277190 Progenitor cells; differentiation; cloning
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276838 Composition and method for viral inhibition
12/15/2005US20050276820 structural modification alters the biological persistence, preferably the biological half-life
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050274671 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/15/2005DE202005015885U1 Pharmaceutical form of medicated moorland water as sweet or spicy dry extrudates, useful for increasing the well being of stomach or intestine tract, comprises grain, spicy mixture and/or flavors
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/15/2005CA2567356A1 Magnesium complexes of s-omeprazole
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604646A1 Viscous compositions containing carbon dioxide
12/14/2005EP1604645A1 Viscous compositions containing carbon dioxide
12/14/2005EP1603556A2 Sod mimic multifunctional compounds for treating inflammatory bowel disease
12/14/2005EP1603544A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo 2.2.1 heptan-2-amine
12/14/2005EP1603542A1 Treatment and/or prevention of non-viral epithelial damage
12/14/2005EP1603537A2 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
12/14/2005EP1483370A4 Hepatocyte precursor cell lines
12/14/2005EP1439847A4 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
12/14/2005EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1267880B1 Low dose entecavir formulation and use
12/14/2005EP1255870B1 5-hydroxytryptamine transporter gene polymorphisms
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005EP0858504B1 Diagnostics and treatments of periodontal disease
12/14/2005CN1708497A 8-substituted imidazopyridines
12/14/2005CN1708480A Carotenoid analogs for the inhibition and amelioration of disease
12/14/2005CN1708309A Therapeutic and/or preventive agent for dyschezia
12/14/2005CN1708295A Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1231490C Erythromycin derivative having novel crystal structures and process for their production
12/14/2005CN1231489C Amine salt of lignan compound
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231477C Potassium salt of (I(S))-omeprazole
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231255C Capsule formula for treating astriction prepared using pumpkin as main raw material and its preparation method
12/14/2005CN1231251C Colitis therapeutic traditional Chinese medicine
12/14/2005CN1231248C Chinese medicine for reinforcing kidney and supporting yang
12/14/2005CN1231244C Health foods for tonification and postponing senility
12/14/2005CN1231241C Renshujianwei granular formulation and its preparation method
12/14/2005CN1231240C Rose and donkey-hide gelatin syrup and its preparation
12/14/2005CN1231234C Formulation of capsule medicine for treating gastropathy
12/14/2005CN1231229C Process for preparing medicated liquid for arresting vomiting and nourishing stomach
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974859 oligopeptide having dental caries protective properties; administering by mouthwash, chewing gum or toothpaste
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974831 sPLA2 inhibitors
1 ... 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 ... 1258